Literature DB >> 1600269

Two fatal cases of hepatitis B virus carriers after corticosteroid therapy for bronchial asthma.

Y Koga1, R Kumashiro, K Yasumoto, S Shakado, N Ono, H Noguchi, K Nagata, M Sata, H Abe, N Kaku.   

Abstract

We report two hepatitis B virus (HBV) carriers who had liver failure after withdrawal of corticosteroids (steroids) administered for treatment of serious asthmatic attacks. Liver functions deteriorated 1 to 2 wk after withdrawal of the steroid therapy and liver failure occurred. Steroid readministration and intensive therapy for liver failure did not prevent death. An excessive immune response provoked by steroid withdrawal and decreased reserve capacity due to underlying chronic liver disease were thought to be factors in the liver failure. Caution must be exercised in the administration of steroids to patients with underlying chronic HBV infection to prevent exacerbation of hepatitis. Prompt readministration of steroids is indicated if evidence of liver failure develops.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600269     DOI: 10.2169/internalmedicine.31.208

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

Review 1.  Management of chronic hepatitis B in patients from special populations.

Authors:  Ching-Lung Lai; Man-Fung Yuen
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

Review 2.  Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.

Authors:  Mariacarla Moleti; Giuseppe Giuffrida; Giacomo Sturniolo; Giovanni Squadrito; Alfredo Campennì; Silvia Morelli; Efisio Puxeddu; Eleonora Sisti; Francesco Trimarchi; Francesco Vermiglio; Michele Marinò
Journal:  Endocrine       Date:  2016-03-22       Impact factor: 3.633

3.  Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy.

Authors:  Hiroyuki Eguchi; Junichi Tani; Saori Hirao; Munehisa Tsuruta; Ichiro Tokubuchi; Kentaro Yamada; Masataka Kasaoka; Yasuo Teshima; Tatsuyuki Kakuma; Yuji Hiromatsu
Journal:  Int J Endocrinol       Date:  2015-06-28       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.